Trials / Unknown
UnknownNCT03668522
Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
Clinical Research of the Molecular Phenotype Distribution of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Southern Medical University, China · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
H3F3AK27M may be a feature of primary spinal cord glioma and affect the outcome and prognosis of TMZ chemoradiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Genetic testing | To determine whether H3F3AK27M exist in spinal glioma |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2018-09-12
- Last updated
- 2018-09-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03668522. Inclusion in this directory is not an endorsement.